ACIP Vaccine Review: CDC Panel Updates
- the Advisory Committee on immunization Practices (ACIP) will conduct a review of vaccines approved for several years, including an examination of the cumulative impact of the childhood vaccine...
- One group will focus on the entire childhood and adolescent vaccine schedules.
- Kulldorff stated the review is necessary to ensure ACIP recommendations align with current scientific research, optimizing benefits for individuals and public health.He emphasized the importance of staying updated...
The ACIP is set to conduct a comprehensive review of long-approved vaccines, including an in-depth look at the cumulative impact of the childhood vaccine schedule on children and adolescents, sparking critical debate. This vaccine review, announced by the new co-chair, Martin Kulldorff, has prompted the American Academy of Pediatrics (AAP) to withdraw, citing a lack of credibility within the process. This decision is an important development in how we understand vaccine policies and safety protocols.This review comes amid claims from skeptics, while authorities reaffirm the safety of the current schedule. News Directory 3 offers insights into the ongoing debate and evolving scientific understanding. Discover what’s next as we track how scientific findings influence immunization practices.
Vaccine Advisory panel to Review Long-Approved Vaccines, Citing Evolving Science
the Advisory Committee on immunization Practices (ACIP) will conduct a review of vaccines approved for several years, including an examination of the cumulative impact of the childhood vaccine schedule. Martin Kulldorff, the new co-chair of the ACIP, announced the review at a hearing in Atlanta. Robert F. Kennedy Jr., secretary of Health, appointed Kulldorff after dismissing previous committee members.
Two new work groups will handle the review. One group will focus on the entire childhood and adolescent vaccine schedules. The other will examine vaccines approved for seven or more years. Specific vaccines mentioned include the hepatitis B shot given to infants and the combination measles, mumps, rubella, and chickenpox vaccine. These vaccines have often been the target of vaccine skeptics.
Kulldorff stated the review is necessary to ensure ACIP recommendations align with current scientific research, optimizing benefits for individuals and public health.He emphasized the importance of staying updated with evolving knowledge about vaccines.
Groups critical of current vaccine policy, including Children’s Health Defense, have long argued that the cumulative effect of multiple vaccines has not been adequately studied. They claim this cumulative exposure could led to harms such as autism,a claim widely refuted by the scientific community. Paul Offit, a pediatrician, dismissed these concerns as long-standing anti-vaccine talking points.
The American Academy of Pediatrics (AAP) announced its withdrawal from the ACIP process. AAP President Susan Kressly stated the newly formed ACIP “is no longer a credible process” in a video posted online.
“We won’t lend our name or our expertise to a system that is being politicized at the expense of children’s health,” Kressly said. The AAP will continue to publish its own immunization schedule.
It remains unclear if other organizations with liaison status on the ACIP will follow the AAP’s lead.A roll call of liaison members was not conducted at the meeting’s start due to technical issues. By early afternoon, liaison members had not contributed to discussions.
The ACIP has previously examined the safety of the vaccine schedule. In 2023, Matthew Daley of Kaiser Permanente presented an analysis drawing from a 2014 CDC white paper that Kulldorf contributed to.The study, utilizing Vaccine Safety Datalink data, found a potential small link between aluminum exposure from vaccines and asthma. However, it concluded that available evidence supports the safety of the routine childhood vaccination schedule.
Offit noted that studies are performed before new vaccines are added to the schedule. These studies show that administering a new vaccine with existing vaccines does not reduce effectiveness or raise safety concerns.
During her confirmation hearing, Susan Monarez, President Trump’s nominee to lead the CDC, addressed Kennedy’s decision to halt U.S. support for Gavi, the Vaccine Alliance. Monarez stated she supports vaccine use, saying, “I think vaccines save lives. I think that we need to continue to support the promotion of utilization of vaccines.”